BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36402232)

  • 1. PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment.
    Yang M; Wang B; Yin Y; Ma X; Tang L; Zhang Y; Fan Q; Yin T; Wang Y
    J Control Release; 2023 Jan; 353():63-76. PubMed ID: 36402232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.
    Shi Y; Ping YF; Zhou W; He ZC; Chen C; Bian BS; Zhang L; Chen L; Lan X; Zhang XC; Zhou K; Liu Q; Long H; Fu TW; Zhang XN; Cao MF; Huang Z; Fang X; Wang X; Feng H; Yao XH; Yu SC; Cui YH; Zhang X; Rich JN; Bao S; Bian XW
    Nat Commun; 2017 Jun; 8():15080. PubMed ID: 28569747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.
    Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
    Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
    [No Abstract]   [Full Text] [Related]  

  • 5. Exosomal miR-6733-5p mediates cross-talk between glioblastoma stem cells and macrophages and promotes glioblastoma multiform progression synergistically.
    Huang S; Liu L; Xu Z; Liu X; Wu A; Zhang X; Li Z; Li S; Li Y; Yuan J; Cheng S; Li H; Dong J
    CNS Neurosci Ther; 2023 Dec; 29(12):3756-3773. PubMed ID: 37309294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma.
    Jiang S; Li W; Yang J; Zhang T; Zhang Y; Xu L; Hu B; Li Z; Gao H; Huang Y; Ruan S
    ACS Nano; 2024 Feb; 18(8):6445-6462. PubMed ID: 38358804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.
    Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S
    Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
    Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
    Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
    Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
    Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated Macrophages.
    Yuan W; Zhang Q; Gu D; Lu C; Dixit D; Gimple RC; Gao Y; Gao J; Li D; Shan D; Hu L; Li L; Li Y; Ci S; You H; Yan L; Chen K; Zhao N; Xu C; Lan J; Liu D; Zhang J; Shi Z; Wu Q; Yang K; Zhao L; Qiu Z; Lv D; Gao W; Yang H; Lin F; Wang Q; Man J; Li C; Tao W; Agnihotri S; Qian X; Mack SC; Zhang N; You Y; Rich JN; Sun G; Wang X
    Clin Cancer Res; 2023 Sep; 29(18):3779-3792. PubMed ID: 37439870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
    Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
    Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.
    Yin J; Kim SS; Choi E; Oh YT; Lin W; Kim TH; Sa JK; Hong JH; Park SH; Kwon HJ; Jin X; You Y; Kim JH; Kim H; Son J; Lee J; Nam DH; Choi KS; Shi B; Gwak HS; Yoo H; Iavarone A; Kim JH; Park JB
    Nat Commun; 2020 Jun; 11(1):2978. PubMed ID: 32532977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages.
    Li D; Zhang Q; Li L; Chen K; Yang J; Dixit D; Gimple RC; Ci S; Lu C; Hu L; Gao J; Shan D; Li Y; Zhang J; Shi Z; Gu D; Yuan W; Wu Q; Yang K; Zhao L; Qiu Z; Lv D; Gao W; Yang H; Lin F; Wang Q; Man J; Li C; Tao W; Agnihotri S; Qian X; Shi Y; You Y; Zhang N; Rich JN; Wang X
    Cancer Res; 2022 Sep; 82(18):3321-3334. PubMed ID: 35841593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy.
    Mendanha D; Vieira de Castro J; Casanova MR; Gimondi S; Ferreira H; Neves NM
    Nanomedicine; 2023 Apr; 49():102663. PubMed ID: 36773669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
    Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
    J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFI35 regulates non-canonical NF-κB signaling to maintain glioblastoma stem cells and recruit tumor-associated macrophages.
    Li D; Wang X; Chen K; Shan D; Cui G; Yuan W; Lin Q; Gimple RC; Dixit D; Lu C; Gu D; You H; Gao J; Li Y; Kang T; Yang J; Yu H; Song K; Shi Z; Fan X; Wu Q; Gao W; Zhu Z; Man J; Wang Q; Lin F; Tao W; Mack SC; Chen Y; Zhang J; Li C; Zhang N; You Y; Qian X; Yang K; Rich JN; Zhang Q; Wang X
    Cell Death Differ; 2024 Jun; 31(6):738-752. PubMed ID: 38594444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.
    Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S
    Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells.
    Huang P; Ouyang DJ; Chang S; Li MY; Li L; Li QY; Zeng R; Zou QY; Su J; Zhao P; Pei L; Yi WJ
    Cell Commun Signal; 2018 Nov; 16(1):92. PubMed ID: 30497491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma.
    Tao W; Chu C; Zhou W; Huang Z; Zhai K; Fang X; Huang Q; Zhang A; Wang X; Yu X; Huang H; Wu Q; Sloan AE; Yu JS; Li X; Stark GR; Rich JN; Bao S
    Nat Commun; 2020 Jun; 11(1):3015. PubMed ID: 32541784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.